Mario Pereira, field application scientist for bioproduction at Horizon Discovery, a PerkinElmer company, comments on the advantages of using CHO cells for biomanufacturing and explains how gene editing technologies are increasing their utility.
Damiano Rossi, head of Applications – Particle Engineering and Microfluidics, Dolomite Microfluidics looks at how computational fluid dynamics modelling and AI are helping scientists predict the outcomes of microfluidic experiments.
Stuart Madden, chief scientific officer at neuroscience company Neurelis, examines the drug delivery sector and the opportunities non-invasive methods present to the industry and patients.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the antibiotics landscape and why we need to speak up about antimicrobial resistance (AMR).
In this episode of The MedTalk Podcast, Ian Bolland joined by Liz Ashall-Payne, founding chief executive of ORCHA to discuss the digital health landscape and its acceleration during Covid-19.
Ben Wylie, senior product manager at ChargePoint Technology, argues that single-use (SU) technology is central to helping biotechs optimise efficiency in order to meet fast-growing demand for biologic treatments.
Jason Webb, director at Electronic Temperature Instruments (ETI) explores the work going into keeping Covid-19 vaccines at a stable temperature for transport.
David Brown, Science and Program director at Qatar Precision Medicine Institute, discusses how blockchain technology is the answer to the healthcare industry’s challenges with storing genomic data.
Dr David Phillips, senior global product technology specialist , clean air at Thermo Fisher Scientific looks at how the adoption of advanced Class II BSCs in cGMP environments is helping to deliver safe and effective medicines.
